Public health, innovation, intellectual property and trade

Second meeting of the WHO Expert Working Group on R&D Financing

The Expert Working Group (EWG) held its second meeting this week. In its meeting, the Group continued its discussions on current financing and coordination of R&D, including the review of the results of the report on Global Funding of Innovation for Neglected Diseases (G-Finder), and it further reviewed the outcomes and findings of other ongoing relevant international initiatives on financing, such as those of Working Group 2 of the High Level Task Force on innovative financing for health systems and The I-8 Group / L.I.F.E. (Leading Innovative Financing for Equity).

The EWG also discussed innovative frameworks for financing R& D as well as examining the coordination of R&D. It reviewed in detail the contributions from its members . The EWG members had received and examined the contributions from member states and also those from other stakeholders that had been solicited through the public hearing. The EWG then further elaborated a process for extended analysis of current R&D financing mechanisms which would include the submitted proposals and other key financing proposals in circulation.

This process will envisage the opportunity for inputs from a wider interested public including member states, individuals, civil society groups, government institutions, academic and research institutions, the private sector and other interested parties. In addition, the EWG plans to provide updates on the work in progress from time to time.

The EWG also discussed a framework for its final report to be presented to the Director-General which would adhere strictly to the mandate established in accordance with the Resolution WHA 61.21 on Global strategy and plan of action on public health, innovation and intellectual property.

Geneva, 1 July 2009